Design and characterization of PEG-derivatized vitamin e as a nanomicellar formulation for delivery of paclitaxel

Molecular Pharmaceutics

Volumn 10, Issue 8, 2013, Pages 2880-2890

  Lu, Jianqin ^a,b   Huang, Yixian ^a,b   Zhao, Wenchen ^a   Chen, Yichao ^a,b   Li, Jiang ^a,b   Gao, Xiang ^a,b   Venkataramanan, Raman ^a   Li, Song ^a,b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

cancer; controlled and sustained drug delivery; nanomicelles; nanotechnology; paclitaxel; TPGS

Indexed keywords

ALPHA TOCOPHEROL; CREMOPHOR; MACROGOL; MULTIDRUG RESISTANCE PROTEIN; PACLITAXEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CANCER INHIBITION; CANCER MODEL; CONTROLLED STUDY; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG FORMULATION; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MICELLE; MOUSE; NANOPHARMACEUTICS; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CELL LINE, TUMOR; CHEMISTRY, PHARMACEUTICAL; FEMALE; HUMANS; MICE; MICE, INBRED BALB C; MICELLES; NANOTECHNOLOGY; PACLITAXEL; POLYETHYLENE GLYCOLS; VITAMIN E;

EID: 84881335670     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp300729y     Document Type: Article

References (35)

1. Torchilin, V. P. Micellar nanocarriers: pharmaceutical perspectives Pharm. Res. 2007, 24, 1-16
2. Sutton, D.; Nasongkla, N.; Blanco, E.; Gao, J. Functionalized micellar systems for cancer targeted drug delivery Pharm. Res. 2007, 24, 1029-1046
3. Mi, Y.; Liu, Y.; Feng, S. S. Formulation of docetaxel by folic acid-conjugated D-α-tocopheryl polyethylene glycol succinate 2000 (Vitamin E TPGS2k) micelles for targeted and synergistic chemotherapy Biomaterials 2011, 32, 4058-4066
4. Matsumura, Y.; Maeda, H. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumouritropic accumulation of proteins and the antitumour agent smancs Cancer Res. 1986, 46, 6387-6392
5. Gao, Z.; Lukyanov, A. N.; Singhal, A.; Torchilin, V. P. Diacyllipid-polymer micelles as nanocarriers for poorly soluble anticancer drugs Nano Lett. 2002, 2, 979-982
6. Croy, S. R.; Kwon, G. S. Polymeric micelles for drug delivery Curr. Pharm. Des. 2006, 12, 4669-4684
7. Sokol, R. J.; Heubi, J. E.; Butler-Simon, N.; McClung, H. J.; Lilly, J. R.; Silverman, A. Treatment of Vitamin E deficiency during chronic childhood cholestasis with oral d-alpha-tocopheryl polyethylene glycol-1000 succinate Gastroenterology 1987, 93, 975-985
8. Yu, L.; Bridgers, A.; Polli, J.; Vickers, A.; Long, S.; Roy, A. Vitamin E-TPGS increases absorption flux of an HIV protease inhibitor by enhancing its solubility and permeability Pharm. Res. 1999, 16, 1812-1817
9. Dintaman, J. M.; Silverman, J. A. Inhibition of P-glycoprotein by D-alpha-tocopheryl polyethylene glycol 1000 succinate (TPGS) Pharm. Res. 1999, 16, 1550-1556
10. Varma, M. V. S.; Panchagnula, R. Enhanced oral paclitaxel absorption with Vitamin E-TPGS: effect on solubility and permeability in vitro, in situ and in vivo Eur. J. Pharm. Sci. 2005, 25, 445-453
11. Collnot, E. M.; Baldes, C.; Schaefer, U. F.; Edgar, K. J.; Wempe, M. F.; Lehr, C. M. Vitamin E TPGS p-glycoprotein inhibition mechanism: influence on conformational flexibility, intracellular ATP levels, and role of time and site of access Mol. Pharmaceutics 2010, 7, 642-51
12. Constantinides, P. P.; Han, J. H.; Davis, S. S. Advances in the use of tocols as drug delivery vehicles Pharm. Res. 2006, 23, 243-255
13. Win, K. Y.; Feng, S. S. In vitro and in vivo studies on Vitamin E TPGS-emulsified poly(D,L-lactic-co-glycolic acid)nanoparticles for paclitaxel formulation Biomaterials 2006, 27, 2285-2291
14. Ma, Y.; Zheng, Y.; Liu, K.; Tian, G.; Tian, Y.; Xu, L.; Yan, F.; Huang, L.; Mei, L. Nanoparticles of poly(lactide-co-glycolide)-d-a-tocopheryl polyethylene glycol 1000 succinate random copolymer for cancer treatment Nanoscale Res. Lett. 2010, 6, 1161-1169
15. Wang, J.; Sun, J.; Chen, Q.; Gao, Y.; Li, L.; Li, H.; Leng, D.; Wang, Y.; Sun, Y.; Jing, Y.; Wang, S.; He, Z. Star-shape copolymer of lysine-linked di-tocopherol polyethylene glycol 2000 succinate for doxorubicin delivery with reversal of multidrug resistance Biomaterials 2012, 28, 6877-6888
16. Muthu, M. S.; Kulkarni, S. A; Xiong, J.; Feng, S. S. Vitamin E TPGS coated liposomes enhanced cellular uptake and cytotoxicity of docetaxel in brain cancer cells Int. J. Pharmaceutics 2011, 421, 332-340
17. Cao, N.; Feng, S. S. Doxorubicin conjugated to D-alpha-tocopheryl polyethylene glycol 1000 succinate (TPGS): conjugation chemistry, characterization, in vitro and in vivo evaluation Biomaterials 2008, 29, 3856-3865
18. Anbharasi, V.; Cao, N.; Feng, S. S. Doxorubicin conjugated to D-alpha-tocopheryl polyethylene glycol succinate and folic acid as a prodrug for targeted chemotherapy J. Biomed. Mater. Res., Part A 2010, 94, 730-743
19. Mert, O.; Lai, S. K.; Ensign, L.; Yang, M.; Wang, Y. Y.; Wood, J.; Hanes, J. A poly(ethylene glycol)-based surfactant for formulation of drug-loaded mucus penetrating particles J. Controlled Release 2012, 157, 455-60
20. Huang, Y.; Lu, J.; Gao, X.; Li, J.; Zhao, W.; Sun, M.; Stolz, D. B.; Venkataramanan, R.; Rohan, L. C.; Li, S. PEG-derivatized embelin as a dual functional carrier for the delivery of paclitaxel Bioconjugate Chem. 2012, 23, 1443-1451
21. Chitra, M.; Sukumar, E.; Suja, V.; Devi, C. S. Antitumor, anti-inflammatory and analgesic property of embelin, a plant product Chemotherapy 1994, 40, 109-113
22. Bhandari, U.; Jain, N.; Pillai, K. K. Further studies on antioxidant potential and protection of pancreatic beta-cells by Embelia ribes in experimental diabetes Exp. Diabetes Res. 2007, 15803-15808
23. Singh, D.; Singh, R.; Singh, P.; Gupta, R. S. Effect of embelin on lipid peroxidation and free radical scavenging activity against liver damage in rats Basic Clin. Pharmacol. Toxicol. 2009, 105, 243-248
24. Danquah, M.; Li, F.; Duke, C. B.; Miller, D. D.; Mahato, R. I. Micellar delivery of bicalutamide and embelin for treating prostate cancer Pharm. Res. 2009, 26, 2081-2092
25. Sreepriya, M.; Bali, G. Chemopreventive effects of embelin and curcumin against N-nitrosodiethylamine/phenobarbital-induced hepatocarcinogenesis in Wistar rats Fitoterapia 2005, 76, 549-555
26. Dai, Y.; Qiao, L.; Chan, K. W.; Yang, M.; Ye, J.; Ma, J.; Zou, B.; Gu, Q.; Wang, J.; Pang, R.; Lan, H. Y.; Wong, B. C. Peroxisome proliferator- activated receptor-gamma contributes to the inhibitory effects of Embelin on colon carcinogenesis Cancer Res. 2009, 69, 4776-4783
27. Heo, J. K.; Kim, H. J.; Kim, S. M.; Park, K. R.; Park, S. Y.; Kim, S. W.; Nam, D.; Jang, H. J.; Lee, S. G.; Ahn, K. S.; Kim, S. H.; Shim, B. S.; Choi, S. H.; Ahn, K. S. Embelin suppresses STAT3 signaling, proliferation, and survival of multiple myeloma via the protein tyrosine phosphatase PTEN Cancer Lett. 2011, 308, 71-80
28. Lu, J.; Huang, Y.; Zhao, W.; Marquez, R. T.; Meng, X.; Li, J.; Gao, X.; Venkataramanan, R.; Wang, Z.; Li, S. PEG-Derivatized Embelin as a Nanomicellar Carrier for Delivery of Paclitaxel to Breast and Prostate Cancers Biomaterials 2013, 34, 1591-600
29. La, S. B.; Okano, T.; Kataoka, K. Preparation and characterization of the micelle-forming polymeric drug indomethacin incorporated poly(ethylene oxide)-poly(beta-benzyl L-aspartate) block copolymer micelles J. Pharm. Sci. 1996, 85, 85-90
30. Kabanov, A. V.; Nazarova, I. R.; Astafieva, I. V.; Batrakova, E. V.; Alakhov, V. Y.; Yaroslavov, A. A.; Kabanov, V. A. Micelle formation and solubilization of fluorescent probes in poly-(oxyethylene-b-oxypropylene-b- oxyethylene) solutions Macromolecules 1995, 28, 2303-2314
31. Collnot, E. M.; Baldes, C.; Wempe, M. F.; Kappl, R.; Hüttermann, J.; Hyatt, J. A.; Edgar, K. J.; Schaefer, U. F.; Lehr, C. M. Mechanism of inhibition of P-glycoprotein mediated efflux by vitamin E TPGS: influence on ATPase activity and membrane fluidity Mol. Pharmaceutics 2007, 4, 465-74
32. Gao, X.; Huang, Y.; Makhov, A. M.; Epperly, M.; Lu, J.; Grab, S.; Zhang, P.; Rohan, L.; Xie, X. Q.; Wipf, P.; Greenberger, J.; Li, S. Nanoassembly of surfactants with interfacial drug-interactive motifs as tailor-designed drug carriers Mol. Pharmacol. 2013, 10, 187-98
33. Luo, J.; Xiao, K.; Li, Y.; Lee, J. S.; Shi, L.; Tan, Y. H.; Xing, L.; Holland Cheng, R.; Liu, G. Y.; Lam, K. S. Well-defined, size-tunable multi-functional micelles for efficient paclitaxel delivery for cancer treatment Bioconjugate Chem. 2010, 21, 1216-1224
34. Zhang, X.; Lu, J.; Huang, Y.; Zhao, W.; Chen, Y.; Li, J.; Gao, X.; Venkataramanan, R.; Sun, M.; Stolz, D. B.; Zhang, L.; Li, S. PEG-Farnesylthiosalicylate conjugate as a nanomicellar carrier for delivery of paclitaxel Bioconjugate Chem. 2013, 24, 464-72
35. Lai, S. K.; Wang, Y. Y.; Hanes, J. Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues Adv. Drug Delivery Rev. 2009, 61, 158-71